UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019603
Receipt number R000022648
Scientific Title Effect of general anesthesia with sevoflurane at age-adjusted concentration on electrocorticography, compared with 2.5% in patients with intractable epilepsy
Date of disclosure of the study information 2015/11/02
Last modified on 2016/12/30 20:19:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of general anesthesia with sevoflurane at age-adjusted concentration on electrocorticography, compared with 2.5% in patients with intractable epilepsy

Acronym

Effect of sevoflurane concentration on the electrocorticography

Scientific Title

Effect of general anesthesia with sevoflurane at age-adjusted concentration on electrocorticography, compared with 2.5% in patients with intractable epilepsy

Scientific Title:Acronym

Effect of sevoflurane concentration on the electrocorticography

Region

Japan


Condition

Condition

intractable epilepsy

Classification by specialty

Neurology Pediatrics Anesthesiology
Neurosurgery Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the optimal concentration of an inhalational anesthetic for surgical treatment of intractable epilepsy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The frequency of spikes during anesthesia

Key secondary outcomes

The area where spikes are detected during anesthesia


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Electrocorticogram is recorded with the end-tidal concentration of sevoflurane at 1.5 x age-adjusted minimum alveolar concentration, followed by recording with the end-tidal concentration of sevoflurane at 2.5%, irrespective of the patients' age.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 years-old <=

Age-upper limit

40 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients undergoing surgical treatment of intractable epilepsy with American Society of Anesthesiologists physical status I-III

Key exclusion criteria

Patients with ischemic heart disease or decreased cardiac function with left ventricular ejection fraction equal to or less than 40%

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yutaka Oda

Organization

Osaka City General Hospital

Division name

Anesthesiology

Zip code


Address

2-13-22 Miyakojima-Hondori, Miyakojima-ku, Osaka

TEL

+81-6-6929-1221

Email

odayou@s5.dion.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yutaka Oda

Organization

Osaka City General Hospital

Division name

Anesthesiology

Zip code


Address

2-13-22 Miyakojima-Hondori, Miyakojima-ku, Osaka

TEL

+81-6-6929-1221

Homepage URL


Email

odayou@s5.dion.ne.jp


Sponsor or person

Institute

Osaka City General Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Anesthesiology, Osaka City General Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The incidence and the number of leads with epileptic discharge in pediatric patients receiving 1.5 MAC sevoflurane were signifcantly larger than those receiving 2.5% sevoflurane.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2015 Year 08 Month 31 Day

Date of IRB


Anticipated trial start date

2015 Year 11 Month 03 Day

Last follow-up date

2016 Year 10 Month 01 Day

Date of closure to data entry

2016 Year 10 Month 01 Day

Date trial data considered complete

2016 Year 10 Month 02 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 02 Day

Last modified on

2016 Year 12 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022648